In addition, recent development in the radiopharmaceutical field has allowed nuclear medicine imaging to be increasingly used in clinical practice and research regarding dementia, by exploring multiple physiopathological aspects of diseases including glucose metabolism, tau and amyloid retention, etc. The role of nuclear medicine in the differential diagnosis of dementia is crucial as it leads to a personalized approach to dementia. This evidence concerns the gene MAPT and dementia.